Hovione Farmaciência SA

Hovione Farmaciência SA

Hovione Farmaciência SA

Overview
Date Founded

1959

Headquarters

QT S. Pedro,Sete Casas,Loures, Lisboa (Lisbon) 2674-506

Type of Company

Private

Industries

Pharmaceuticals
Wholesale: Consumer Non-Durables/Sundries
Medical Products & Equipment

Company Description

Hovione FarmaCiencia SA manufactures and distributes active pharmaceutical ingredients. Its services include contract manufacturing services, off-patent API products, proprietary product licensing, and supporting capabilities. The company was founded by Diane de Lancastre Houssemayne Du Boulay Villax, Ivan Villax, Nicholas de Horthy and Andrew Onody in 1959 and is headquartered in Loures, Portugal.

Contact Data
Trying to get in touch with decision makers at Hovione Farmaciência SA? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Executive Officer & Director

Chief Financial Officer

General Manager, Loures Plant

General Manager, Ireland

General Manager, New Jersey

General Manager, RD Loures

General Manager, Macau

Vice President, Human Resources

Vice President, Engineering

Board of Directors

Professor at Peking University

Founder at Hovione Farmaciência SA

Former Head of Digital Marketing at Samsung Electronics America, Inc.

Chief Executive Officer & Director at Hovione Farmaciência SA

Former Head-Corporate Communications at Hovione Farmaciência SA

President & Chief Executive Officer at Ferring Holding SA

Paths to Hovione Farmaciência SA
Potential Connections via
Relationship Science
You
Hovione Farmaciência SA
Clients

Intersect ENT, Inc. is a commercial drug delivery company, which engages in the treatment of ear, nose, and throat conditions. The company was founded by Donald J. Eaton in October 2003 and is headquartered in Menlo Park, CA.

Nabriva Therapeutics Plc is a clinical stage biopharmaceutical company, which engages in the research and development of novel antibiotics to treat serious infections. Its product pipeline includes Lefamulin, CONTEPO, and BC-7013. The company was founded in October 2005 and is headquartered in Dublin, Ireland.

Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Hovione Farmaciência SA. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Hovione Farmaciência SA's profile does not indicate a business or promotional relationship of any kind between RelSci and Hovione Farmaciência SA.